<?xml version="1.0"?>
<rss version="2.0"><channel><title>Recalls Latest Topics</title><link>https://bmetgalaxy.com/forums/index.php?/forum/23-recalls/</link><description>Recalls Latest Topics</description><language>en</language><item><title>Intravascular Administration Set Recall: Baxter Removes Duo-Vent Solution Sets</title><link>https://bmetgalaxy.com/forums/index.php?/topic/2575-intravascular-administration-set-recall-baxter-removes-duo-vent-solution-sets/</link><description><![CDATA[Baxter administration sets may have air bubbles in the drip chamber and tubing, which may result in air being delivered through the IV line to the patient.<p><a href="http://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/intravascular-administration-set-recall-baxter-removes-duo-vent-solution-sets" rel="external nofollow">View the full article</a></p>]]></description><guid isPermaLink="false">2575</guid><pubDate>Thu, 13 Aug 2026 04:00:00 +0000</pubDate></item><item><title>Convenience Kit Correction: Medline Issues Correction for Convenience Kits Containing ICU Medical Pain Management Components</title><link>https://bmetgalaxy.com/forums/index.php?/topic/2574-convenience-kit-correction-medline-issues-correction-for-convenience-kits-containing-icu-medical-pain-management-components/</link><description><![CDATA[Medline is correcting affected convenience kits by removing included ICU Medical pain management components containing Huons Bupivacaine Hydrochloride in Dextrose Injection, USP.  <p><a href="http://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/convenience-kit-correction-medline-issues-correction-convenience-kits-containing-icu-medical-pain" rel="external nofollow">View the full article</a></p>]]></description><guid isPermaLink="false">2574</guid><pubDate>Wed, 12 Aug 2026 04:00:00 +0000</pubDate></item><item><title>Update on Alert: Convenience Kit Issue from Medline</title><link>https://bmetgalaxy.com/forums/index.php?/topic/2573-update-on-alert-convenience-kit-issue-from-medline/</link><description><![CDATA[Certain BD ChloraPrep Applicators in Convenience Kits manufactured by Medline may not be sterile.  <p><a href="http://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/update-alert-convenience-kit-issue-medline" rel="external nofollow">View the full article</a></p>]]></description><guid isPermaLink="false">2573</guid><pubDate>Wed, 12 Aug 2026 04:00:00 +0000</pubDate></item><item><title>Breathing Circuit Set Recall: Hamilton Medical Removes Breathing Circuit Set</title><link>https://bmetgalaxy.com/forums/index.php?/topic/2571-breathing-circuit-set-recall-hamilton-medical-removes-breathing-circuit-set/</link><description><![CDATA[The ventilator breathing circuits are intended to connect a ventilator to a patient tube or mask. Obstruction may result in inadequate ventilation.<p><a href="http://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/breathing-circuit-set-recall-hamilton-medical-removes-breathing-circuit-set" rel="external nofollow">View the full article</a></p>]]></description><guid isPermaLink="false">2571</guid><pubDate>Tue, 11 Aug 2026 04:00:00 +0000</pubDate></item><item><title>Fresenius Kabi Issues Nationwide Recall of Tyenne&#xAE; (tocilizumab-aazg) Injection 400 mg/20 mL Vials Due to Presence of Glass Particles </title><link>https://bmetgalaxy.com/forums/index.php?/topic/2570-fresenius-kabi-issues-nationwide-recall-of-tyenne%C2%AE-tocilizumab-aazg-injection-400-mg20-ml-vials-due-to-presence-of-glass-particles/</link><description><![CDATA[FOR IMMEDIATE RELEASE – August 10, 2026 – LAKE ZURICH, Ill.— Fresenius Kabi, an operating company of the Fresenius Group, is recalling one lot of Tyenne® (tocilizumab-aazg) Injection 400 mg/20 mL (20 mg/mL)20 mL vials to the user level. An internal investigation at the firm found the product to cont<p><a href="http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/fresenius-kabi-issues-nationwide-recall-tyenner-tocilizumab-aazg-injection-400-mg20-ml-vials-due" rel="external nofollow">View the full article</a></p>]]></description><guid isPermaLink="false">2570</guid><pubDate>Tue, 11 Aug 2026 04:00:00 +0000</pubDate></item><item><title>Catheter Introducer Correction: Abiomed and Oscor Issue Correction for Catheter Introducer</title><link>https://bmetgalaxy.com/forums/index.php?/topic/2569-catheter-introducer-correction-abiomed-and-oscor-issue-correction-for-catheter-introducer/</link><description><![CDATA[Abiomed and Oscor have identified a potential for introducer sheath leakage in 14Fr and 23Fr Introducers that may increase the risk of access-site bleeding.<p><a href="http://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/catheter-introducer-correction-abiomed-and-oscor-issue-correction-catheter-introducer" rel="external nofollow">View the full article</a></p>]]></description><guid isPermaLink="false">2569</guid><pubDate>Mon, 10 Aug 2026 04:00:00 +0000</pubDate></item><item><title>Medline Industries, LP Issues Nationwide Recall of Hudson RCI Neonatal/Infant Heated Wire Breathing Circuits </title><link>https://bmetgalaxy.com/forums/index.php?/topic/2565-medline-industries-lp-issues-nationwide-recall-of-hudson-rci-neonatalinfant-heated-wire-breathing-circuits/</link><description><![CDATA[On July 13, 2026, Medline Industries, LP initiated a nationwide recall of Hudson RCI Neonatal/Infant Heated Wire Breathing Circuits. Medline received reports of sporadic failures involving the electrical connector of certain neonatal and infant heated wire breathing circuits. In affected circuits, t<p><a href="http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/medline-industries-lp-issues-nationwide-recall-hudson-rci-neonatalinfant-heated-wire-breathing" rel="external nofollow">View the full article</a></p>]]></description><guid isPermaLink="false">2565</guid><pubDate>Thu, 06 Aug 2026 04:00:00 +0000</pubDate></item><item><title>Victory Medical Center Pharmacy Issues Voluntary Nationwide Recall of Certain Lots of Compounded Glutathione 200 mg/mL Multi-Dose Vials Due to  Elevated Endotoxin Levels</title><link>https://bmetgalaxy.com/forums/index.php?/topic/2557-victory-medical-center-pharmacy-issues-voluntary-nationwide-recall-of-certain-lots-of-compounded-glutathione-200-mgml-multi-dose-vials-due-to-elevated-endotoxin-levels/</link><description><![CDATA[FOR IMMEDIATE RELEASE – August 5, 2026 – Austin, Texas, Victory Medical Center Pharmacy is voluntarily recalling certain lots of Compounded Glutathione 200 mg/mL Multi-Dose Vials to the patient level. The product is being recalled because pharmacy testing identified elevated bacterial endotoxin leve<p><a href="http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/victory-medical-center-pharmacy-issues-voluntary-nationwide-recall-certain-lots-compounded" rel="external nofollow">View the full article</a></p>]]></description><guid isPermaLink="false">2557</guid><pubDate>Wed, 05 Aug 2026 04:00:00 +0000</pubDate></item><item><title>Fresenius Kabi Issues Voluntary Nationwide Recall of One Lot of Morphine Sulfate Injection, USP in a Simplist&#xAE; Prefilled Syringe Due to Labeling Mix-up</title><link>https://bmetgalaxy.com/forums/index.php?/topic/2552-fresenius-kabi-issues-voluntary-nationwide-recall-of-one-lot-of-morphine-sulfate-injection-usp-in-a-simplist%C2%AE-prefilled-syringe-due-to-labeling-mix-up/</link><description><![CDATA[FOR IMMEDIATE RELEASE – 8/4/2026 – LAKE ZURICH, Ill.— Fresenius Kabi, an operating company of the Fresenius Group, is voluntarily recalling one lot of Morphine Sulfate Injection USP, Simplist® 2 mg/1 mL due to a label mix-up. The MicroVault labeled as Morphine 2 mg/1 mL, may contain a Prefilled Syri<p><a href="http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/fresenius-kabi-issues-voluntary-nationwide-recall-one-lot-morphine-sulfate-injection-usp-simplistr" rel="external nofollow">View the full article</a></p>]]></description><guid isPermaLink="false">2552</guid><pubDate>Wed, 05 Aug 2026 04:00:00 +0000</pubDate></item><item><title>Early Alert: Intraosseous Needle Set Issue from Becton Dickinson</title><link>https://bmetgalaxy.com/forums/index.php?/topic/2543-early-alert-intraosseous-needle-set-issue-from-becton-dickinson/</link><description><![CDATA[BD is recalling certain BD Intraosseous Vascular Access System Needle Sets due to difficulty removing the obturator (stylet) following placement.<p><a href="http://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/early-alert-intraosseous-needle-set-issue-becton-dickinson" rel="external nofollow">View the full article</a></p>]]></description><guid isPermaLink="false">2543</guid><pubDate>Tue, 04 Aug 2026 04:00:00 +0000</pubDate></item><item><title>Liebel-Flarsheim Company, LLC Issues Recall of OPTIRAY Imaging Bulk Package - 350, 500mL, Vial, Nationwide and Mexico Due to Presence of Particulate Matter </title><link>https://bmetgalaxy.com/forums/index.php?/topic/2542-liebel-flarsheim-company-llc-issues-recall-of-optiray-imaging-bulk-package-350-500ml-vial-nationwide-and-mexico-due-to-presence-of-particulate-matter/</link><description><![CDATA[FOR IMMEDIATE RELEASE – July 31, 2026 – Raleigh, North Carolina, Liebel-Flarsheim Company, LLC, is recalling one lot of OPTIRAY Imaging Bulk Package (IBP) 350, 500mL in vial, (Ioversol Injection 74% 350 mg iodine/ml) for intra-arterial or intra-venous use to the user level (hospitals, imaging center<p><a href="http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/liebel-flarsheim-company-llc-issues-recall-optiray-imaging-bulk-package-350-500ml-vial-nationwide" rel="external nofollow">View the full article</a></p>]]></description><guid isPermaLink="false">2542</guid><pubDate>Tue, 04 Aug 2026 04:00:00 +0000</pubDate></item><item><title>BD Issues Nationwide Recall for Specific Lots of BD&#xAE; Intraosseous Vascular Access System Needle Sets Due to Reports of Difficulty Removing the Obturator</title><link>https://bmetgalaxy.com/forums/index.php?/topic/2539-bd-issues-nationwide-recall-for-specific-lots-of-bd%C2%AE-intraosseous-vascular-access-system-needle-sets-due-to-reports-of-difficulty-removing-the-obturator/</link><description><![CDATA[FRANKLIN LAKES, N.J.  (July 31, 2026) – BD (Becton, Dickinson and Company) is voluntarily recalling specific lots of BD® Intraosseous Vascular Access System Needle Sets to the user level. These products are being recalled following reports that some users experienced difficulty removing the obturato<p><a href="http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/bd-issues-nationwide-recall-specific-lots-bdr-intraosseous-vascular-access-system-needle-sets-due" rel="external nofollow">View the full article</a></p>]]></description><guid isPermaLink="false">2539</guid><pubDate>Mon, 03 Aug 2026 04:00:00 +0000</pubDate></item><item><title>Convenience Kit Correction: Medical Action Industries Issues Correction for Kits Containing Recalled Namic Manifolds</title><link>https://bmetgalaxy.com/forums/index.php?/topic/2537-convenience-kit-correction-medical-action-industries-issues-correction-for-kits-containing-recalled-namic-manifolds/</link><description><![CDATA[Particulates have the potential to be introduced into blood circulation and become lodged within blood vessels.<p><a href="http://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/convenience-kit-correction-medical-action-industries-issues-correction-kits-containing-recalled" rel="external nofollow">View the full article</a></p>]]></description><guid isPermaLink="false">2537</guid><pubDate>Mon, 03 Aug 2026 04:00:00 +0000</pubDate></item><item><title>American Regent, Inc. Animal Health Issues Nationwide Recall of Two Lots of Adequan&#xAE; Canine and Two Lots of Adequan&#xAE; I.M. Due to Visible Glass Fiber Material in the Product</title><link>https://bmetgalaxy.com/forums/index.php?/topic/2536-american-regent-inc-animal-health-issues-nationwide-recall-of-two-lots-of-adequan%C2%AE-canine-and-two-lots-of-adequan%C2%AE-im-due-to-visible-glass-fiber-material-in-the-product/</link><description><![CDATA[FOR IMMEDIATE RELEASE – July 31, 2026 – Shirley, NY, American Regent, Inc. Animal Health is conducting a nationwide recall of two lots (25011 and 3369) of Adequan® Canine Injection (for dogs), 100 mg/mL 5mL multi-dose vials and two lots (24416 and 25265P) of Adequan® i.m. Injection (for horses), 500<p><a href="http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/american-regent-inc-animal-health-issues-nationwide-recall-two-lots-adequanr-canine-and-two-lots" rel="external nofollow">View the full article</a></p>]]></description><guid isPermaLink="false">2536</guid><pubDate>Mon, 03 Aug 2026 04:00:00 +0000</pubDate></item><item><title>Convenience Kit Correction: Medline Issues Correction for Kits Containing Huons Lidocaine Hydrochloride and Bupivacaine Hydrochloride in Dextrose Injection</title><link>https://bmetgalaxy.com/forums/index.php?/topic/2535-convenience-kit-correction-medline-issues-correction-for-kits-containing-huons-lidocaine-hydrochloride-and-bupivacaine-hydrochloride-in-dextrose-injection/</link><description><![CDATA[Medline is correcting affected convenience kits by removing recalled Lidocaine Hydrochloride and Bupivacaine Hydrochloride in Dextrose Injection components from affected convenience kits.  <p><a href="http://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/convenience-kit-correction-medline-issues-correction-kits-containing-huons-lidocaine-hydrochloride" rel="external nofollow">View the full article</a></p>]]></description><guid isPermaLink="false">2535</guid><pubDate>Mon, 03 Aug 2026 04:00:00 +0000</pubDate></item><item><title>Ventilator Correction: Resmed Issues Correction for Astral Ventilator</title><link>https://bmetgalaxy.com/forums/index.php?/topic/2499-ventilator-correction-resmed-issues-correction-for-astral-ventilator/</link><description><![CDATA[Failure of an electrical component in certain Astral ventilators may cause an interruption or failure in therapy which may result in serious injury or death.<p><a href="http://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/ventilator-correction-resmed-issues-correction-astral-ventilator" rel="external nofollow">View the full article</a></p>]]></description><guid isPermaLink="false">2499</guid><pubDate>Fri, 31 Jul 2026 04:00:00 +0000</pubDate></item><item><title>Convenience Kit Correction: Argon Medical Issues Correction for Convenience Kits Containing Spectra Medical Device Lidocaine Ampules </title><link>https://bmetgalaxy.com/forums/index.php?/topic/2498-convenience-kit-correction-argon-medical-issues-correction-for-convenience-kits-containing-spectra-medical-device-lidocaine-ampules/</link><description><![CDATA[Argon Medical is correcting affected convenience kits by removing included Spectra Medical Devices Lidocaine Ampules.  <p><a href="http://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/convenience-kit-correction-argon-medical-issues-correction-convenience-kits-containing-spectra" rel="external nofollow">View the full article</a></p>]]></description><guid isPermaLink="false">2498</guid><pubDate>Thu, 30 Jul 2026 04:00:00 +0000</pubDate></item><item><title>American Regent, Inc. Issues Voluntary Nationwide Recall of One Lot of Papaverine Hydrochloride Injection, USP 60 mg/ 2 mL Due to the Presence of Visible Particulate Matter</title><link>https://bmetgalaxy.com/forums/index.php?/topic/2494-american-regent-inc-issues-voluntary-nationwide-recall-of-one-lot-of-papaverine-hydrochloride-injection-usp-60-mg-2-ml-due-to-the-presence-of-visible-particulate-matter/</link><description><![CDATA[July 24, 2026 – Shirley, NY, American Regent, Inc. is conducting a nationwide voluntary recall of a single lot of Papaverine Hydrochloride Injection, USP, 60 mg/2 mL single dose vial to the consumer level. The product is being recalled due to the presence of particulate matter identified as glass an<p><a href="http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/american-regent-inc-issues-voluntary-nationwide-recall-one-lot-papaverine-hydrochloride-injection" rel="external nofollow">View the full article</a></p>]]></description><guid isPermaLink="false">2494</guid><pubDate>Mon, 27 Jul 2026 04:00:00 +0000</pubDate></item><item><title>Baxter Issues Voluntary Nationwide Recall of Cefazolin in Dextrose Injection, USP, 2G / 100ml(20mg /ml) Single-Dose Infusion Bag in 100ml Due to Particulate Matter Found in Solution</title><link>https://bmetgalaxy.com/forums/index.php?/topic/2567-baxter-issues-voluntary-nationwide-recall-of-cefazolin-in-dextrose-injection-usp-2g-100ml20mg-ml-single-dose-infusion-bag-in-100ml-due-to-particulate-matter-found-in-solution/</link><description><![CDATA[July 24, 2026 – DEERFIELD, Ill., Baxter International Inc. (NYSE:BAX) is voluntarily recalling Lot LD175708, Exp 14-Feb 2027 of Cefazolin in Dextrose Injection due to a report of particulate matter found in the solution identified as cardboard.Risk Statement: The use of the defective product has a <p><a href="http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/baxter-issues-voluntary-nationwide-recall-cefazolin-dextrose-injection-usp-2g-100ml20mg-ml-single" rel="external nofollow">View the full article</a></p>]]></description><guid isPermaLink="false">2567</guid><pubDate>Fri, 24 Jul 2026 04:00:00 +0000</pubDate></item><item><title>Early Alert: Percutaneous Catheter Issue from Boston Scientific</title><link>https://bmetgalaxy.com/forums/index.php?/topic/2497-early-alert-percutaneous-catheter-issue-from-boston-scientific/</link><description><![CDATA[ENROUTE Transcarotid Neuroprotection Systems may have arterial sheath tip separation or partial tip separation during use<p><a href="http://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/early-alert-percutaneous-catheter-issue-boston-scientific" rel="external nofollow">View the full article</a></p>]]></description><guid isPermaLink="false">2497</guid><pubDate>Fri, 24 Jul 2026 04:00:00 +0000</pubDate></item><item><title>Sunny Pharmtech, Inc. Issues Voluntary Nationwide Recall of Cyclophosphamide for Injection, USP to the User Level Due to the Presence of Particulate Matter</title><link>https://bmetgalaxy.com/forums/index.php?/topic/2496-sunny-pharmtech-inc-issues-voluntary-nationwide-recall-of-cyclophosphamide-for-injection-usp-to-the-user-level-due-to-the-presence-of-particulate-matter/</link><description><![CDATA[July 24, 2026 - Taoyuan City, Taiwan - Sunny Pharmtech, Inc is voluntarily recalling three lots of Cyclophosphamide for Injection, USP, 1g/vial and 2g/vial, to the User Level due to the presence of particulate matter identified as steel. To date, no adverse events or injuries associated with this pa<p><a href="http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/sunny-pharmtech-inc-issues-voluntary-nationwide-recall-cyclophosphamide-injection-usp-user-level-due" rel="external nofollow">View the full article</a></p>]]></description><guid isPermaLink="false">2496</guid><pubDate>Fri, 24 Jul 2026 04:00:00 +0000</pubDate></item><item><title>BAXTER ISSUES VOLUNTARY NATIONWIDE RECALL OF CEFAZOLIN IN DEXTROSE INJECTION, USP, 2G / 100ML (20MG / ML) SINGLE-DOSE INFUSION BAG IN 100ML DUE TO PARTICULATE MATTER FOUND IN SOLUTION</title><link>https://bmetgalaxy.com/forums/index.php?/topic/2495-baxter-issues-voluntary-nationwide-recall-of-cefazolin-in-dextrose-injection-usp-2g-100ml-20mg-ml-single-dose-infusion-bag-in-100ml-due-to-particulate-matter-found-in-solution/</link><description><![CDATA[July 24, 2026 – DEERFIELD, Ill., Baxter International Inc. (NYSE:BAX) is voluntarily recalling Lot LD175708, Exp 14-Feb 2027 of Cefazolin in Dextrose Injection due to a report of particulate matter found in the solution identified as cardboard.<br />
Risk Statement: The use of the defective product has a <p><a href="http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/baxter-issues-voluntary-nationwide-recall-cefazolin-dextrose-injection-usp-2g-100ml-20mg-ml-single" rel="external nofollow">View the full article</a></p>]]></description><guid isPermaLink="false">2495</guid><pubDate>Fri, 24 Jul 2026 04:00:00 +0000</pubDate></item><item><title><![CDATA[Unique Pharmaceutical Laboratories (A Div. of J. B. Chemicals & Pharmaceuticals Ltd.) Issues Voluntary Nationwide Recall of Cetirizine Hydrochloride Tablets USP 5 mg Due to Potential Cross Contamination with Ranitidine ]]></title><link>https://bmetgalaxy.com/forums/index.php?/topic/2471-unique-pharmaceutical-laboratories-a-div-of-j-b-chemicals-pharmaceuticals-ltd-issues-voluntary-nationwide-recall-of-cetirizine-hydrochloride-tablets-usp-5-mg-due-to-potential-cross-contamination-with-ranitidine/</link><description><![CDATA[FOR IMMEDIATE RELEASE – July 18th, 2026 – Panoli, Gujarat, Unique Pharmaceutical Laboratories (A Div. of J. B. Chemicals &amp; Pharmaceuticals Ltd.) is voluntarily recalling four lots of Cetirizine Hydrochloride Tablets USP 5 mg to the consumer level due to cross contamination with Ranitidine.<p><a href="http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/unique-pharmaceutical-laboratories-div-j-b-chemicals-pharmaceuticals-ltd-issues-voluntary-nationwide" rel="external nofollow">View the full article</a></p>]]></description><guid isPermaLink="false">2471</guid><pubDate>Mon, 20 Jul 2026 04:00:00 +0000</pubDate></item><item><title>Early Alert: Intravascular Administration Set Issue from Baxter</title><link>https://bmetgalaxy.com/forums/index.php?/topic/2470-early-alert-intravascular-administration-set-issue-from-baxter/</link><description><![CDATA[Baxter administration sets may have air bubbles in the drip chamber and tubing, which may result in air being delivered through the IV line to the patient.<p><a href="http://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/early-alert-intravascular-administration-set-issue-baxter" rel="external nofollow">View the full article</a></p>]]></description><guid isPermaLink="false">2470</guid><pubDate>Mon, 20 Jul 2026 04:00:00 +0000</pubDate></item><item><title>Catheter Introducer Kit Recall:  Abiomed Removes 14Fr Low Profile Introducer Kits  </title><link>https://bmetgalaxy.com/forums/index.php?/topic/2452-catheter-introducer-kit-recall-abiomed-removes-14fr-low-profile-introducer-kits/</link><description><![CDATA[Prolonged use of the Abiomed 14Fr Low Profile Introducer may lead to thrombus formation.<p><a href="http://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/catheter-introducer-kit-recall-abiomed-removes-14fr-low-profile-introducer-kits" rel="external nofollow">View the full article</a></p>]]></description><guid isPermaLink="false">2452</guid><pubDate>Fri, 17 Jul 2026 04:00:00 +0000</pubDate></item></channel></rss>
